Cervivor Founder: A Voice for Cervical Cancer Survivors and Health Equity This Black Philanthropy Month

When Tamika Felder founded Cervivor, Inc., in 2005, she wasn’t trying to build a national nonprofit with global reach. She was simply navigating her own cervical cancer diagnosis and determined that no woman should feel as alone as she once did.

Today, as Founder and Chief Visionary of Cervivor, Tamika leads an international movement to eliminate cervical cancer and confront health disparities—especially those affecting women of color.

During Black Philanthropy Month—and on Give 8/28, a national day dedicated to uplifting Black-led and Black-benefiting nonprofits—Tamika’s story is a powerful reminder of how Black leaders are driving change in health equity and advocacy. For her, the day is rooted in pride and visibility. “I’ve always been a part of community service,” she says, reflecting on the example set by her parents. “There are so many Black organizations doing incredible work, but they don’t always get the recognition they deserve. Give 8/28 is a day to say we’re proud to lead these organizations.”

Here, Tamika shares her wisdom and advice for others—whether you’re launching a nonprofit or fighting for access to quality healthcare for all.

Finding Her ‘Why’ and Reclaiming Her Voice

One of Tamika’s guiding messages as a leader and survivor is the importance of finding your “why”—the driving force behind your advocacy work and passion. For her, that “why” was born during cancer treatment and its aftermath, as she grieved the sudden end of her career as an up-and-coming broadcast journalist in Washington, D.C., and the loss of her fertility. “Little by little, the trauma had less of a hold on my life, and I began to embrace the possibilities that life beyond cancer could hold,” she says.

A pivotal moment came when she was asked to testify in support of a Maryland law to safeguard parenthood for young adult cancer patients. “Through tears and shaky hands, I shared my story with legislators, and it made a difference,” she recalls. The Protect Parenthood law was ultimately passed in 2018. Since then, Tamika has continued to use her powerful voice—speaking on Presidential Panels and global stages, serving on national roundtables, and appearing in award-winning documentaries and major publications.

“Black Philanthropy Month is about increasing visibility for Black-led nonprofits,” she says. “Some people might look at Cervivor and think, ‘Well, it already has great visibility.’ But until cervical cancer is eliminated, it will always need more.”

Centering Health Equity

Tamika has always been clear: While the mission of Cervivor is universal—cervical cancer prevention and elimination—the path forward must address inequities that disproportionately affect Black and brown women. And she doesn’t mince words about why health equity is central to her work. “We know that there are disparity gaps in this space, and that people of color, especially Black and brown women, are falling through those gaps at a higher incidence,” she explains.

Cervical cancer is one of the most preventable cancers. With the HPV vaccine, Pap tests, HPV testing, and now self-collection options, the prevention tools exist to save lives. Yet Black women continue to face higher rates of diagnosis and death. Tamika believes part of the solution lies in representation: survivors telling their own stories and trusted messengers bringing information to their communities.

The image is a graphic featuring a quote and a photograph. The quote, displayed on the left side of the image, reads: "MY LEGACY WOULDN'T BE THE LIVES I BROUGHT INTO THE WORLD. IT WAS GOING TO BE THE LIVES THAT I SAVED." The text is presented in a large, bold font, with the words "MY LEGACY," "WAS GOING TO BE THE," and "LIVES THAT I SAVED" in teal, and "WOULDN'T BE THE," "LIVES I BROUGHT," and "IT" in red and orange.
To the right of the quote is a photograph of a group of eight women, all wearing white or light-colored shirts with the word "cervivor" printed on them. They are seated on two white couches, arranged in a conversational manner. The background of the photograph features a wood-paneled wall adorned with a large piece of artwork.
At the bottom-right corner of the image, three logos are visible. The first logo, situated closest to the photograph, reads "cervivor" in teal text, accompanied by the tagline "informed. empowered. alive." in smaller text below. The second logo, positioned to the right of the first, displays the name "Tamika Felder" in orange text. The overall design of the image suggests that it may be related to a campaign or organization focused on cervical cancer awareness or support.
Cervivor Noir community members at last year’s Cervical Cancer Patient Advocacy Retreat For Communities of Color in Cleveland, OH.

“When I first started sharing my story, I didn’t see anyone who looked like me,” she says. “Every time I see a Black woman sharing their story and sharing the correct scientific information behind cervical cancer, it makes me feel really, really proud.”

The Power of Patient Stories

Tamika has built Cervivor around the conviction that data alone is not enough. “We gave the data, but we didn’t tell the story,” a researcher once told her. That insight reshaped her advocacy.

“You hear all the time that patient stories are important, but I uniquely got it,” Tamika reflects. “My story makes a difference. The hard parts of my story that I may not want to talk about can make a difference. ”From Cleveland to Rwanda, Cervivor has seen an impact by uplifting patient voices. At a Cleveland Clinic event, Cervivor ensured that “no one was left out of the screening” by providing culturally specific support through Cervivor Español and Cervivor Noir.

These stories matter because they reveal the lived reality of surviving cervical cancer—the hysterectomies, infertility, ostomies, and lifelong side effects often invisible to the public. “If we just let the general population tell it, well, you survived it, you’re doing fine. But I don’t look like what I’ve been through,” Tamika says.

Building Trust and Representation

Trust is everything in underserved communities, and Tamika insists on meeting people where they are. “I go to those communities. If I don’t go myself, someone from my organization goes. We talk to them. We build trust,” she says.

Representation plays a central role in Cervivor’s impact. Tamika works to ensure that photos, videos, and programs reflect diverse survivors. “I never want anyone not to see themselves,” she explains. “There’s something special to be said by connecting with people who’ve gone through what you’ve gone through.”

Resilience and Self-Care in Leadership

Running a nonprofit rooted in lived trauma is deeply personal work, and Tamika is candid about the toll. “There are points where it’s going to be really hard, but when you’re really committed to this work, you’ll find a way to keep going,” she says.

The image is a collage of 84 headshots of women, arranged in six rows, with a light blue background that gradually darkens towards the top. The headshots are presented in white-bordered boxes, each containing a photo of a woman and her name, along with her birth and death years. The women depicted are diverse in terms of age, ethnicity, and attire. At the bottom of the image, the text "WITH CERVIVOR, THEY LIVE ON #ENDCERVICALCANCER" is displayed in white, accompanied by the Cervivor logo in the bottom-right corner. The overall tone of the image is somber, as it appears to be a tribute to women who have passed away from cervical cancer.

Tamika with Lisa Simms Booth, Executive Director of the Smith Center for Healing and the Arts

As a survivor herself, every death in the community is another wound. “It’s another person who’s died from a preventable disease, and so I have to really practice self-care around that,” she shares. Surrounding herself with other Black women nonprofit leaders helps her carry the weight. “It’s a very hard time, not only for nonprofits, but nonprofits run by Black women. Knowing that you’re not alone helps it be manageable.”

Standing Firm on Equity

Even as some organizations shy away from terms like “DEI” or “health equity” in response to political pressures, Tamika refuses to dilute Cervivor’s mission. “Just because we change and don’t call a thing a thing doesn’t mean that we don’t experience it,” she says. “We’ve already had a funder not fund us because of our Communities of Color retreat. And I’m not going to change the name of it. No one is going to die from cervical cancer on my watch.”

Her vision is clear: to leave behind a legacy of courage, visibility, and unrelenting advocacy.

A Legacy of Hope and Action

What began as one woman’s way to not feel alone has become a global movement of survivors, advocates, and educators. Tamika is proud of how Cervivor has connected patients, clinicians, community workers, and researchers. “We’ve inspired patients, educated clinicians, and shifted the narrative around cervical cancer,” she says.

On Black Philanthropy Day, her journey reminds us that philanthropy is not just about giving money—it’s about giving voice, visibility, and leadership. Tamika embodies all three, leading with resilience and purpose to ensure that no one falls through the gaps in the fight against cervical cancer.

Support the Mission

This Black Philanthropy Month, we invite you to support Tamika’s vision and Cervivor’s mission to end cervical cancer through advocacy, education, and community. Here’s how you can take action:  

  • Give $20 on 8/28: As part of Cervivor’s year-long Tell 20, Give 20 campaign, your $20 donation will directly support a Black-led nonprofit committed to health equity for all. 
  • Engage with Cervivor: Follow us on social media, share our posts, and help amplify the voices of cervical cancer survivors and advocates. Your engagement builds awareness, strengthens our community, and inspires action.
  • Attend Cervivor Events: From Cervivor School and monthly virtual meetups to the next Cervical Cancer Summit—your presence makes a difference. Show up, speak out, and stand with us.

Cervical Cancer Prevention Starts Here: HPV Vaccine Facts You Can Trust

By Kyle Minnis, Cervivor Communications Assistant

The United States, along with much of the world, is at a pivotal moment in cancer prevention. Various studies show that use of the human papillomavirus (HPV) vaccine—which can prevent over 90% of HPV-related cancers, including cervical cancer—is falling. If the trend continues, more children and families will face potentially life-threatening cancer diagnoses that could be avoided. 

The numbers speak for themselves: According to the Centers for Disease Control’s (CDC) most recent National Immunization Survey, only 78% of U.S. adolescents aged 13 to 17 have received at least one dose of the HPV vaccine, and fewer than 63% are up to date on the full series. This is significantly below the national Healthy People 2030 goal of 80% two-dose completion among adolescents aged 13 to 15. Recent data suggests the pandemic has widened gaps in vaccine uptake and fueled vaccine hesitancy.

Globally, approximately 31% of eligible girls have received at least one dose, though the percentage fully completing the recommended series falls well short of the World Health Organization (WHO) cervical cancer elimination target of 90% completion by age 15. The disease still claims the lives of nearly 400,000 people with a cervix worldwide each year.

As vaccine misinformation floods social media, parents and young adults encounter more conflicting messages than ever. Meanwhile, research infrastructure is under threat. In March 2025, the National Institutes of Health (NIH) terminated all funded research on vaccine hesitancy and uptake, telling scientists: “This award no longer effectuates agency priorities.” 

“Watching the headlines and talking to experts in the field, we know this is a critical time,” says cervical cancer survivor Tamika Felder, Cervivor’s Founder and Chief Visionary and co-chair of the American Cancer Society’s National HPV Vaccination Roundtable. “Respected scientists are being dismissed. Research is being defunded. ‘Vaccine’ has become an even more loaded word. And decades of hard-earned progress are at risk.” 

Cervivor Founder Tamika (center) addresses the audience at the 2025 National HPV Conference, a key gathering for leaders in HPV prevention.

For Cervivor Ambassador Zuli Garcia, who will mark her second cancer-versary this November, the issue is deeply personal. As a 2024 Cervivor School graduate and founder of Knock and Drop Iowa, she advocates for underserved families who often face barriers to timely HPV cancer prevention. “I’m living proof of what happens when access comes too late,” says Zuli, who was diagnosed at age 47. “The HPV vaccine represents hope, protection, and equity.”

To cut through the noise and offer clear, trustworthy HPV vaccine facts during National Immunization Awareness Month (NIAM), we’ve gathered insights from survivors and leading experts. What follows is a breakdown of the most essential information about the HPV vaccine—and why it’s needed to protect future generations from preventable cancers.

Why HPV Vaccination Matters More Than Ever

Every major health authority agrees: The HPV vaccine saves lives from cervical cancer and five other HPV-related cancers—including anal, throat, penile, vaginal, and vulvar cancers. Among teen girls, infections with the HPV types that cause most cancers have dropped by 88%, while infections among young women have dropped by 81%, according to a 2024 CDC report. Additionally, among vaccinated women, cervical precancers caused by high-risk HPV types have declined by 40%, with some studies showing up to 80% reductions in high-grade lesions among those vaccinated early.

In countries like Australia and Sweden—thanks to widespread vaccination and strong screening programs—HPV is close to being eliminated as a cause of cervical cancer. 

Dr. Heather Brandt

Dr. Heather Brandt, director of the HPV Cancer Prevention Program at St. Jude Children’s Research Hospital, stresses both the progress made and the work still ahead. “Here we are after almost 20 years of the vaccination being available and still working to make sure people understand how HPV vaccination protects against these diseases,” she says. She recalls feeling “such excitement” at the 2002 International Papillomavirus Conference when early trial results showed the vaccine could prevent HPV-related diseases, pre-cancers, cancers, genital warts, and even recurrent respiratory papillomatosis.

Today, after more than 15 years and over 500 million doses given worldwide, the vaccine’s safety record remains excellent. Serious side effects are extremely rare, and most reactions are mild, such as temporary soreness or fever. Real-world studies confirm that protection lasts at least 12 years—and likely much longer.

Who Should Get the HPV Vaccine and When?

Everyone—regardless of gender—should get the HPV vaccine. Here are the latest immunization guidelines: 

  • The ideal time to start is between ages 11 and 12, though it can be given as early as age 9 for maximum protection. 
  • If the first dose is given before age 15, only two doses are needed. 
  • For those starting later or who are immunocompromised, a three-dose series is recommended. 
  • Catch-up vaccination is advised through age 26, and adults up to age 45 may still benefit based on individual risk and guidance from their healthcare provider.

The following infographic provides additional information on when and why the vaccine is so important for saving lives from preventable cancers.

While insurance coverage for older teens and adults varies, several states—including Washington D.C., Virginia, Rhode Island, and Hawaii, plus Puerto Rico—have implemented school-entry requirements for the HPV vaccine. These policies significantly boost community-wide protection.

“HPV affects everyone—men and women—and the vaccine is about cancer prevention, not lifestyle choices,” says a spokesperson from Vaccinate Your Family, an organization dedicated to raising awareness about timely immunizations. Its current #FirstDayVax campaign aligns with CDC recommendations to bundle the HPV vaccine with other routine back-to-school shots, like Tdap and meningitis. 

Common HPV Vaccine Myths—and How to Address Them

Across the U.S.—especially in rural and conservative communities—misinformation and stigma are stalling progress. Rising non-medical exemptions, often fueled by online disinformation, threaten decades of gains for all vaccines, not just HPV. Without research and infrastructure support, public health programs are left without the tools they need to respond.

Kellie DeFelice

As Vaccinate Your Family warns: “Parents are increasingly exposed to false vaccine claims online, where algorithms and bots amplify misleading content and make anti-vaccine rhetoric appear as credible as scientific consensus.” 

Even parents who support vaccines can be swayed. Kellie Defelice, a Cervivor Ambassador, shares: “I was very pro-vaccine. But after reading a story online, I hesitated and turned down the HPV vaccine for my daughter. I regretted that decision when I was diagnosed with cervical cancer.” Her hope for fellow moms: “They see that I’m the real face of what HPV does—it isn’t just an STI. I risked my daughter getting a cancer that has destroyed so much for me.”

Other common myths include:

  • “The HPV vaccine is just for girls.” In fact, HPV affects everyone. Anal cancer rates in both men and women have been rising, with new cases increasing by about 2.2% per year over the past decade, according to the American Cancer Society. While men may not get cervical cancer, they can still contract and spread high-risk HPV strains.
  • “The vaccine encourages promiscuity.” Zuli explains that some parents worry the vaccine is a “permission slip for sex.” But as Vaccinate Your Family counters, “Vaccination does not change behavior—it simply protects against cancer-causing infections.”
  • “The vaccine isn’t necessary until kids are sexually active.” In reality, the vaccine works best before HPV exposure, which is why health organizations now recommend it for children as young as 9 years old.

How to Get Back on Track with HPV Vaccination Targets

Survivors and experts are pushing back against misinformation with evidence, stories, and culturally relevant outreach. Zuli says: “As a survivor, I’ll keep raising my voice until every child, every family, and every community has access to this protection.”

A review of nearly 60 studies conducted between 2006 and 2019 found that strong provider recommendations are among the most important—if not the most important—drivers of vaccine uptake, underscoring the need to equip health professionals with confidence and clarity in vaccine conversations.

Community partnerships also make a difference. In Memphis, the St. Jude HPV Cancer Prevention Program helped boost county vaccination rates by 19%, outpacing national averages. In Iowa, Zuli’s team at Knock and Drop Iowa combines bilingual education with on-site vaccinations—reaching 23 people in a single afternoon, she reports. “Meeting people where they are is what works,” Zuli explains. “Education first, vaccines immediately after, in a trusted setting.”

Cervivor Ambassador Zuli Garcia hosts an HPV vaccine outreach event in her home state of Iowa.

Vaccinate Your Family echoes this approach: “Conversations about vaccines should always start with empathy, not judgment. Questions about safety, side effects, or the need for certain vaccines are natural—and families should look to trusted, science-based sources.”

St. Jude’s Dr. Brandt highlights new “compelling” research: “Through our work…we have been discussing the implications of possible changes to the dosing schedule with partners. I know all of us are incredibly excited about the prospect of moving to a single dose in the U.S.”

She also offers caution: “We previously leaned in on the rigor of the FDA-approval processes for childhood vaccinations and then review by the Advisory Committee on Immunization Practices. Key changes to these entities may call into question the science. Changes in dosing with any gaps in evidence become fodder for purveyors of misinformation.”

Ultimately, cancer prevention shouldn’t be controversial—it should be celebrated. By recommitting to science, survivor voices, and trusted outreach, we can ensure every person has the chance to thrive, free from preventable cancers.

If you found this blog post helpful, please share it with friends or family members of recommended vaccination age. You may just save a life. 

About the Author

The image is a portrait of a young man with dark skin and short, curly black hair. He is wearing a blue collared shirt and black-framed glasses, and is smiling at the camera.
The man has dark skin and short, curly black hair.
His hair is cut close to his head, with a slight fade at the sides.
His eyebrows are thick and well-groomed.
He is wearing a blue collared shirt.
The shirt is a medium blue color and appears to be made of a lightweight material.
It has a relaxed fit and is buttoned up to the top.
He is also wearing black-framed glasses.
The frames are rectangular in shape and have a subtle curve at the temples.
The lenses are clear and do not appear to have any tint or coating.
The man is smiling at the camera.
His smile is wide and genuine, showing off his white teeth.
His eyes are crinkled at the corners, giving him a friendly and approachable appearance.
The background of the image is a plain gray color.
The gray is a medium tone, neither too light nor too dark.
It provides a neutral backdrop that allows the subject to stand out.
Overall, the image presents a friendly and approachable young man who appears to be confident and comfortable in front of the camera

Kyle Minnis is a senior studying Strategic Communications at the University of Kansas. He is currently serving as Cervivor’s Communications Assistant.